Key result
Oral administration of glycyrrhizic acid combined with intramuscular foot-and-mouth disease vaccination enhanced systemic and mucosal immunity, achieving a 100% survival rate post-challenge in mice compared to 40% with vaccine alone.
Why the study?
Commercial foot-and-mouth disease vaccines have drawbacks, including a short duration of immune response and local adverse reactions, prompting the need for a vaccination strategy to improve systemic immunity.
Absolute Event Rate: 100% vs 40%
Combining oral glycyrrhizic acid with intramuscular FMD vaccination enhances mucosal and systemic immunity and improves host protection against viral challenge in animal models.
This is the authors' abstract. We don't add key points for this paper.
Background: Commercial foot-and-mouth disease (FMD) vaccines have several drawbacks, including a short duration of the immune response after vaccination and local adverse reactions at the vaccination site. Therefore, we developed a new vaccination strategy that simultaneously improves the health status of the host and stimulates systemic immunity by combining the oral administration of glycyrrhizic acid (GA) and intramuscular injection of the FMD vaccine. Methods: We evaluated the efficacy of the oral immune enhancer GA in conjunction with an intramuscular injection of the FMD vaccine. After vaccination, the experimental (mice) and target animals (pigs) were orally administered GA daily for 4 weeks and once a week for the next 4 weeks. Subsequently, we evaluated safety using various biochemical serum assays, the efficacy of inducing immune responses using serological assays, and the expression of genes related to systemic immunity induction. Results: Oral administration of GA in combination with an intramuscular injection of the FMD vaccine enhanced early, mid-term, and long-term immunity in experimental and target animals. We also confirmed that this co-administration increased the expression of secretory IgA (sIgA), an important indicator of mucosal immunity. Additionally, significant gene elevations in systemic immune markers along with T helper (Th) immune responses were observed. Conclusion: These findings suggest that combining the oral administration of GA with the intramuscular injection of an inactivated FMD vaccine can induce a potent and sustained immune response and stimulate the systemic immune system by promoting sIgA and cytokine gene expression. Our research can be used to enhance the efficacy of existing commercial vaccines as well as control other animal diseases by improving the host's immune system.
GA co-administration may enhance FMD vaccine durability in livestock; leaves open field efficacy and broader applicability.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2025) studied Foot-and-mouth disease (FMD) vaccination. Oral glycyrrhizic acid with intramuscular FMD vaccine vs. Intramuscular FMD vaccine alone (Positive Control) or PBS (Negative Control) was evaluated on Survival rate post-challenge with FMDV (in mice). Oral administration of glycyrrhizic acid combined with intramuscular foot-and-mouth disease vaccination enhanced systemic and mucosal immunity, achieving a 100% survival rate post-challenge in mice compared to 40% with vaccine alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: